Properties (62)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
pharmaceutical drug
|
| gptkbp:activeDuring |
gptkb:Netarsudil
|
| gptkbp:activeYears |
2017
|
| gptkbp:administrativeDivision |
once daily
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:availableIn |
prescription medication
|
| gptkbp:brand |
gptkb:Rhopressa
|
| gptkbp:chemicalFormula |
C22H28N4O4S
indole derivatives |
| gptkbp:clinicalTrials |
Phase 3
ongoing studies ophthalmology improved pressure control included in glaucoma management proven in trials |
| gptkbp:contraindication |
eye irritation
hypersensitivity to components |
| gptkbp:developedBy |
gptkb:Aerie_Pharmaceuticals
|
| gptkbp:dosageForm |
solution
|
| gptkbp:drugInterdiction |
available online
none significant local absorption reduces aqueous humor production |
| gptkbp:firstAppearance |
2017-12-18
|
| gptkbp:formulation |
eye drops
sterile solution |
| gptkbp:hasCapacity |
available through manufacturers
|
| gptkbp:hasPopulation |
adults
|
| gptkbp:healthcare |
important for efficacy
important for proper use |
| https://www.w3.org/2000/01/rdf-schema#label |
Netarsudil
|
| gptkbp:insuranceAccepted |
may vary by plan
|
| gptkbp:is_monitored_by |
intraocular pressure
|
| gptkbp:mandates |
lowering intraocular pressure
|
| gptkbp:marketedAs |
gptkb:Canada
gptkb:European_Union gptkb:United_States |
| gptkbp:marketSegment |
available
|
| gptkbp:offers |
varies by pharmacy
|
| gptkbp:packaging |
bottle with dropper
|
| gptkbp:patentAssignee |
gptkb:Aerie_Pharmaceuticals
|
| gptkbp:regulatoryCompliance |
FDA_approved
|
| gptkbp:research |
pharmaceutical industry
|
| gptkbp:research_areas |
antiglaucoma agent
|
| gptkbp:researchFocus |
glaucoma treatment
|
| gptkbp:researchInterest |
published in medical journals
|
| gptkbp:route |
topical
ocular |
| gptkbp:safetyFeatures |
generally well tolerated
not for injection |
| gptkbp:sells |
gptkb:Rhopressa
|
| gptkbp:sideEffect |
headache
eye discomfort dry eye corneal verticillata eye redness |
| gptkbp:storage |
room temperature
|
| gptkbp:supplyChain |
widely available
regulated by health authorities |
| gptkbp:targets |
intraocular pressure
|
| gptkbp:triggerType |
Rho kinase inhibitor
|
| gptkbp:usedFor |
treatment of glaucoma
|